Heng Reng Investments

Shares of Sinovac Biotech Ltd. (NASDAQ: SVA) were trading up more than 13 percent in Thursday's pre-market session after the company announced it received a non-binding proposal letter from a consortium of investors to acquire the company for $7.00 per share. The consortium includes PKU V-...